In the same NEALS study which serially measured NfL levels in ALS [34], only two (MCP-1 and IL-18) out of sixty-five CSF cytokines evaluated were associated with rates of disease progression. This evidence concerns the gene CCL2 and amyotrophic lateral sclerosis.